{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T02:39:41Z","timestamp":1782441581757,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100197"],"award-info":[{"award-number":["81100197"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670342"],"award-info":[{"award-number":["81670342"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870356"],"award-info":[{"award-number":["81870356"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970376"],"award-info":[{"award-number":["81970376"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["19XD1423600"],"award-info":[{"award-number":["19XD1423600"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["20QA1409000"],"award-info":[{"award-number":["20QA1409000"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"publisher","award":["201540217"],"award-info":[{"award-number":["201540217"]}],"id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["18ZR1438800"],"award-info":[{"award-number":["18ZR1438800"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.yjmcc.2021.07.010","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T23:13:33Z","timestamp":1627686813000},"page":"9-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["MicroRNA-663 prevents monocrotaline-induced pulmonary arterial hypertension by targeting TGF-\u03b21\/smad2\/3 signaling"],"prefix":"10.1016","volume":"161","author":[{"given":"Pan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianxian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongwen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.yjmcc.2021.07.010_bb0005","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1172\/JCI33452","article-title":"Molecular pathogenesis of pulmonary arterial hypertension","volume":"118","author":"Rabinovitch","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.yjmcc.2021.07.010_bb0010","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.jacc.2018.12.076","article-title":"Anatomy, function, and dysfunction of the right ventricle: JACC state-of-the-art review","volume":"73","author":"Sanz","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.07.010_bb0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yjmcc.2007.09.006","article-title":"Pathogenic mechanisms of pulmonary arterial hypertension","volume":"44","author":"Chan","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"5","key":"10.1016\/j.yjmcc.2021.07.010_bb0020","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1055\/s-0033-1356496","article-title":"Pathology and pathobiology of pulmonary hypertension","volume":"34","author":"Guignabert","year":"2013","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"1 Suppl","key":"10.1016\/j.yjmcc.2021.07.010_bb0025","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jacc.2009.04.006","article-title":"Inflammation, growth factors, and pulmonary vascular remodeling","volume":"54","author":"Hassoun","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25 Suppl","key":"10.1016\/j.yjmcc.2021.07.010_bb0030","doi-asserted-by":"crossref","first-page":"D13","DOI":"10.1016\/j.jacc.2013.10.035","article-title":"Genetics and genomics of pulmonary arterial hypertension","volume":"62","author":"Soubrier","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.07.010_bb0035","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/CIRCULATIONAHA.108.821504","article-title":"Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease","volume":"119","author":"Long","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.yjmcc.2021.07.010_bb0040","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2353\/ajpath.2009.080565","volume":"174","author":"Thomas","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.yjmcc.2021.07.010_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003910","article-title":"Sulfur dioxide protects against collagen accumulation in pulmonary artery in association with downregulation of the transforming growth factor beta1\/Smad pathway in pulmonary hypertensive rats","volume":"5","author":"Yu","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"8","key":"10.1016\/j.yjmcc.2021.07.010_bb0050","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1164\/rccm.200707-1083OC","article-title":"Role of the TGF-beta\/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension","volume":"177","author":"Zaiman","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.07.010_bb0055","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1183\/09031936.00174908","article-title":"Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension","volume":"34","author":"Selimovic","year":"2009","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.07.010_bb0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","article-title":"Metazoan MicroRNAs","volume":"173","author":"Bartel","year":"2018","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.yjmcc.2021.07.010_bb0065","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/CIRCRESAHA.112.267591","article-title":"A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples","volume":"111","author":"Caruso","year":"2012","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.yjmcc.2021.07.010_bb0070","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/HYPERTENSIONAHA.114.04600","article-title":"miR-29a-3p attenuates hypoxic pulmonary hypertension by inhibiting pulmonary adventitial fibroblast activation","volume":"65","author":"Luo","year":"2015","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.yjmcc.2021.07.010_bb0075","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/CIRCULATIONAHA.115.016382","article-title":"Downregulation of MicroRNA-126 contributes to the failing right ventricle in pulmonary arterial hypertension","volume":"132","author":"Potus","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.yjmcc.2021.07.010_bb0080","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20101812","article-title":"Role for miR-204 in human pulmonary arterial hypertension","volume":"208","author":"Courboulin","year":"2011","journal-title":"J. Exp. Med."},{"issue":"45","key":"10.1016\/j.yjmcc.2021.07.010_bb0085","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1093\/eurheartj\/ehs060","article-title":"AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension","volume":"35","author":"Brock","year":"2014","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.yjmcc.2021.07.010_bb0090","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/CIRCULATIONAHA.111.060269","article-title":"MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach","volume":"125","author":"Parikh","year":"2012","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.yjmcc.2021.07.010_bb0095","doi-asserted-by":"crossref","first-page":"10973","DOI":"10.1074\/jbc.M112.434340","article-title":"The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2)","volume":"288","author":"Hu","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.yjmcc.2021.07.010_bb0100","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1158\/1078-0432.CCR-13-2284","article-title":"Primate-specific miR-663 functions as a tumor suppressor by targeting PIK3CD and predicts the prognosis of human glioblastoma","volume":"20","author":"Shi","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.yjmcc.2021.07.010_bb0105","doi-asserted-by":"crossref","first-page":"H1762","DOI":"10.1152\/ajpheart.00829.2010","article-title":"MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells","volume":"300","author":"Ni","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.07.010_bb0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.atherosclerosis.2012.06.016","article-title":"Permissive role of miR-663 in induction of VEGF and activation of the ATF4 branch of unfolded protein response in endothelial cells by oxidized phospholipids","volume":"225","author":"Afonyushkin","year":"2012","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.yjmcc.2021.07.010_bb0115","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/CIRCRESAHA.113.301306","article-title":"MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation","volume":"113","author":"Li","year":"2013","journal-title":"Circ. Res."},{"issue":"1\u20132","key":"10.1016\/j.yjmcc.2021.07.010_bb0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11010-011-0723-7","article-title":"Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2","volume":"351","author":"Zhu","year":"2011","journal-title":"Mol. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.yjmcc.2021.07.010_bb0125","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1159\/000488161","article-title":"Pim-1 kinase phosphorylates cardiac troponin I and regulates cardiac myofilament function","volume":"45","author":"Zhu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"5","key":"10.1016\/j.yjmcc.2021.07.010_bb0130","first-page":"L615","article-title":"Nur77 limits endothelial barrier disruption to LPS in the mouse lung","volume":"317","author":"Zhu","year":"2019","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"2","key":"10.1016\/j.yjmcc.2021.07.010_bb0135","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.atherosclerosis.2010.12.024","article-title":"Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration","volume":"215","author":"Zhu","year":"2011","journal-title":"Atherosclerosis"},{"issue":"3\u20134","key":"10.1016\/j.yjmcc.2021.07.010_bb0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1293\/tox.2014-0022","article-title":"Intratracheal instillation methods and the distribution of administered material in the lung of the rat","volume":"27","author":"Hasegawa-Baba","year":"2014","journal-title":"J. Toxicol. Pathol."},{"issue":"110","key":"10.1016\/j.yjmcc.2021.07.010_bb0145","doi-asserted-by":"crossref","DOI":"10.3791\/53335","article-title":"Hemodynamic characterization of rodent models of pulmonary arterial hypertension","author":"Ma","year":"2016","journal-title":"J. Vis. Exp."},{"issue":"9","key":"10.1016\/j.yjmcc.2021.07.010_bb0150","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/nprot.2008.138","article-title":"Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats","volume":"3","author":"Pacher","year":"2008","journal-title":"Nat. Protoc."},{"issue":"19","key":"10.1016\/j.yjmcc.2021.07.010_bb0155","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/heartjnl-2017-312106","article-title":"Pulmonary arterial hypertension in adult congenital heart disease","volume":"104","author":"Brida","year":"2018","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.yjmcc.2021.07.010_bb0160","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/heartjnl-2018-314025","article-title":"Assessment of reversibility in pulmonary arterial hypertension and congenital heart disease","volume":"105","author":"van der Feen","year":"2019","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.yjmcc.2021.07.010_bb0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cytogfr.2004.03.003","article-title":"PDGF signaling in cells and mice","volume":"15","author":"Tallquist","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"issue":"10","key":"10.1016\/j.yjmcc.2021.07.010_bb0170","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1172\/JCI24838","article-title":"Reversal of experimental pulmonary hypertension by PDGF inhibition","volume":"115","author":"Schermuly","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2021.07.010_bb0175","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-3-319-22671-2_12","article-title":"microRNA and pulmonary hypertension","volume":"888","author":"Boucherat","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.07.010_bb0180","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/cvr\/cvr299","article-title":"MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling","volume":"93","author":"McDonald","year":"2012","journal-title":"Cardiovasc. Res."},{"issue":"21","key":"10.1016\/j.yjmcc.2021.07.010_bb0185","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.jacc.2015.03.549","article-title":"Reducing in-stent restenosis: therapeutic manipulation of miRNA in vascular remodeling and inflammation","volume":"65","author":"McDonald","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"23","key":"10.1016\/j.yjmcc.2021.07.010_bb0190","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/j.jacc.2016.09.945","article-title":"MicroRNAs in cardiovascular disease","volume":"68","author":"Barwari","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.07.010_bb0195","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/cvr\/cvw174","article-title":"Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review","volume":"111","author":"Navickas","year":"2016","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.07.010_bb0200","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cvr\/cvx187","article-title":"MicroRNA-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1","volume":"114","author":"Baptista","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.07.010_bb0205","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1164\/rccm.201205-0839OC","article-title":"Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension","volume":"187","author":"Rhodes","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.yjmcc.2021.07.010_bb0210","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1378\/chest.14-2169","article-title":"Discordant regulation of microRNA between multiple experimental models and human pulmonary hypertension","volume":"148","author":"Schlosser","year":"2015","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.yjmcc.2021.07.010_bb0215","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cellsig.2016.06.022","article-title":"The role of PDGF-B\/TGF-beta1\/neprilysin network in regulating endothelial-to-mesenchymal transition in pulmonary artery remodeling","volume":"28","author":"Song","year":"2016","journal-title":"Cell. Signal."},{"issue":"11","key":"10.1016\/j.yjmcc.2021.07.010_bb0220","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1172\/JCI57734","article-title":"Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease","volume":"121","author":"Ma","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.07.010_bb0225","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/cmi.2018.1","article-title":"MicroRNA-663 induces immune dysregulation by inhibiting TGF-beta1 production in bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus","volume":"16","author":"Geng","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.yjmcc.2021.07.010_bb0230","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3892\/or.2015.4432","article-title":"MicroRNA-663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF-beta1","volume":"35","author":"Li","year":"2016","journal-title":"Oncol. Rep."},{"issue":"9","key":"10.1016\/j.yjmcc.2021.07.010_bb0235","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.4161\/rna.34345","article-title":"MiR-663 inhibits radiation-induced bystander effects by targeting TGFB1 in a feedback mode","volume":"11","author":"Hu","year":"2014","journal-title":"RNA Biol."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.07.010_bb0240","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s12276-018-0068-3","article-title":"MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-beta1 and IL-6\/STAT3 signaling pathways","volume":"50","author":"Cai","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"9","key":"10.1016\/j.yjmcc.2021.07.010_bb0245","first-page":"3984","article-title":"MiR-21 regulates pulmonary hypertension in rats via TGF-beta1\/Smad2 signaling pathway","volume":"23","author":"Ding","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282821001516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282821001516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:00:05Z","timestamp":1762668005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282821001516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":49,"alternative-id":["S0022282821001516"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2021.07.010","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-663 prevents monocrotaline-induced pulmonary arterial hypertension by targeting TGF-\u03b21\/smad2\/3 signaling","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2021.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}